1
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc, REID Scott W, May 4, 2006: WO/2006/047516 (17 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


2
Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S: Protein kinase inhibitors and methods for using thereof. Irm, Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S, TONGCO WU Emily, December 24, 2008: WO/2008/157575 (15 worldwide citation)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provid ...


3
Chen Bei, Jiang Tao, Marsilje Thomas H, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Gao Zhaobo, Ge Yonghui, Huang Chen, Li Yuncheng: Compounds and compositions as protein kinase inhibitors. Irm, Novartis, Chen Bei, Jiang Tao, Marsilje Thomas H, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Gao Zhaobo, Ge Yonghui, Huang Chen, Li Yuncheng, sTONGO WU Emily, October 15, 2009: WO/2009/126515 (13 worldwide citation)

The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kina ...


4
Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing, REID Scott W, June 26, 2008: WO/2008/076754 (9 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


5
Jiang Tao, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Zhu Xuefeng: Compounds and compositions as kinase inhibitors. Irm, Jiang Tao, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Zhu Xuefeng, TONGO WU Emily, October 15, 2009: WO/2009/126514 (8 worldwide citation)

The invention relates to triazine and pyrimidine derivatives having Formula (1) or (2), and methods for using such compounds. For example, the compounds of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, ...


6
Alper Phillip, Azimioara Mihai, Cow Christopher, Epple Robert, Jiang Songchun, Lelais Gerald, Michellys Pierre Yves, Nguyen Truc Ngoc, Westcott Baker Lucas, Wu Baogen: Compounds and compositions as modulators of gpr119 activity. Irm, Alper Phillip, Azimioara Mihai, Cow Christopher, Epple Robert, Jiang Songchun, Lelais Gerald, Michellys Pierre Yves, Nguyen Truc Ngoc, Westcott Baker Lucas, Wu Baogen, REID Scott, August 14, 2008: WO/2008/097428 (6 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising compound of following formula (I), and methods of using such compounds to treat or prevent diseases or disorders associated with theactivity of GPR119 (G protein-coupled receptor 119) such as obesity, diabetes and hyperlipidemi ...


7

8
CHEN BEI, JIANG TAO, MICHELLYS PIERRE YVES, NGUYEN TRUC NGOC, PEI WEI, WU BAOGEN, GAO ZHAOBO, GE YONGHUI, HUANG CHEN, LI YUNCHENG, MARSILJE THOMAS H III, ZHU XUEFENG: COMPOSES ET COMPOSITIONS COMME INHIBITEURS DE LA PROTEINE KINASE, COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS. IRM, Novartis, IRM, Novartis, FETHERSTONHAUGH & CO, May 28, 2013: CA2720946

The invention pro-vides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimi-dine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibi-tion of anaplastic lymphoma k ...


9
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Composes et compositions servant dinhibiteurs dactivite de recepteur cannabinoide de type 1, Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Irm, Fetherstonhaugh & Co, October 25, 2011: CA2581225

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


10